TROG (EORTC for NL)
A.H. Westenberg
A.E. van Leeuwen-Stok
TROG Trial Centre fax +61 396561420 email Janani.Sivasuthan@petermac.org
QART
Funding by KWF
Randomisation B: Arm 1: Whole breast RT alone using standard fractionation Arm 3: Whole breast RT using standard fractionation plus tumour bed boost Or Randomisation C: Arm 2: Whole breast RT alone using shorter fractionation ; Arm 4: Whole breast RT using shorter fractionation plus tumour bed boost
To improve the outcome of women with non-low risk DCIS treated with breast conserving therapy. To evaluate time to local recurrence in women with DCIS treated with breast conserving surgery followed by: whole breast RT alone versus whole breast RT plus tumour bed boost; RT using the standard fractionation schedule versus the shorter schedule.
Primar endpoint:
Secondary endpoints:
DCIS (non-low risk) treated by BCS Clinically node-negative =>18 years Female
